로딩 중…
지수 로딩 중…
LigaChem Biosciences Inc.
141080· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩134,600+0.07%
2026-06-19
Price Chart
LigaChem Biosciences Inc.+25.68%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 4.98T KRW |
| Revenue | 125.87B KRW |
| Net Income | -151.33B KRW |
| Total Assets | 652.93B KRW |
| Net Assets | 500.52B KRW |
| Employees | 174 |
| Value | |
| P/B | 9.96x |
| P/S | 39.59x |
| FCF Yield | -2.50% |
| Profitability | |
| ROE | -30.23% |
| ROA | -23.18% |
| Op. Margin | -123.37% |
| Revenue Growth | -30.42% |
| Earnings Growth | -225.81% |
| Financial Health | |
| Debt Ratio | 30.45% |
| Total Debt | 0 KRW |
| FCF | -124.53B KRW |
| Cash | 63.48B KRW |
| Current Ratio | 10.12x |
| Performance | |
| 1Y Return | 25.68% |
| 1M Return | -2.60% |
| From 52W High | -40.18% |
| 1Y MDD | -45.43% |
| Trading | |
| Volume | 346,880 shares |
| Foreign Own. | 11.49% |
| Per Share | |
| EPS | -3,772 KRW |
| BPS | 12,705 KRW |
Company Info
LegoChem Biosciences, established in 2006 and headquartered in Yuseong-gu, Daejeon, is a research-oriented pharmaceutical company listed on KOSDAQ in 2013. The company developed the medicinal chemistry-based original Antibody-Drug Conjugate (ADC) technology named ConjuALL, driving global commercialization through ADC anticancer drug research and development and technology transfer. Through "Beyond ADC" research, it focuses on developing bispecific antibody ADCs, immuno-oncology drugs, and combination therapies, while also securing stable revenue from medical device and consumable sales.